RT Journal Article
T1 Non‑alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism
A1 Cornejo Pareja, Isabel María
A1 Mohamed-Reda, Amiar
A1 Ocaña-Wilhelmi, Luis Tomás
A1 Soler Humanes, Rocio
A1 Arranz-Salas, Isabel María
A1 Garrido-Sánchez, Lourdes
A1 Gutiérrez-Repiso, Carolina
A1 Tinahones-Madueño, Francisco José
K1 Hígado - Enfermedades
K1 Metabolismo - Alteraciones
K1 Obesidad
K1 Hepatitis
AB Alterations in gut microbiota are associated with the pathogenesis of metabolic diseases, including metabolic-associated fatty liver disease (MAFLD). The aim of this study was to evaluate gut microbiota composition and functionality in patients with morbid obesity with different degrees of MAFLD, as assessed by biopsy.
PB Springer Nature
YR 2024
FD 2024-01-24
LK https://hdl.handle.net/10630/29349
UL https://hdl.handle.net/10630/29349
LA spa
NO Cornejo-Pareja, I., Amiar, M.R., Ocaña-Wilhelmi, L. et al. Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism. J Gastroenterol (2024). https://doi.org/10.1007/s00535-023-02075-7
NO Funding for open Access charge: Universidad de Málaga / CBUA.This work was supported in part by a grant from the Ministry of Health and Families of Junta de Andalucía (PI-0108-2022). (“A way to make Europe”). This study was co-funded by FEDER funds. I.C.-P. was the recipient of a postdoctoral grant (Río Hortega CM 17/00169), and is now the recipient of a post-doctoral grant (Juan Rodes JR 19/00054) from the Instituto de Salud Carlos III and co-funded by Fondo Europeo de Desarrollo Regional-FEDER. L.G.-S. is supported by the Nicolas Monardes program from Consejería de Salud de Andalucía (Spain) (C-0028-2018). C.G.-R. was supported by the Miguel Servet program from the Instituto de Salud Carlos III (CP20/00066).
DS RIUMA. Repositorio Institucional de la Universidad de Málaga
RD 24 ene 2026